762 related articles for article (PubMed ID: 18163003)
21. [Anti-VEGF therapy resistance in neovascular age-related macular degeneration].
Budzinskaya MV; Plyukhova AA; Sorokin PA
Vestn Oftalmol; 2017; 133(4):103-108. PubMed ID: 28980574
[TBL] [Abstract][Full Text] [Related]
22. The VEGF paradox: Does diabetic retinopathy protect from age related macular degeneration?
Saravia M; Zeman L; Ingolotti M; Schlaen A
Med Hypotheses; 2017 Nov; 109():156-161. PubMed ID: 29150277
[TBL] [Abstract][Full Text] [Related]
23. Bevacizumab for choroidal neovascularization secondary to age-related macular degeneration and pathological myopia.
Hashemi S; Faramarzi MA; Ghasemi Falavarjani K; Abdollahi M
Expert Opin Biol Ther; 2014 Dec; 14(12):1837-48. PubMed ID: 25283631
[TBL] [Abstract][Full Text] [Related]
24. NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH ADVANCED VISUAL LOSS TREATED WITH ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY: Clinical Outcome and Prognostic Indicators.
Vogel RN; Davis DB; Kimura BH; Rathinavelu S; Graves GS; Szabo A; Han DP
Retina; 2017 Feb; 37(2):257-264. PubMed ID: 27429385
[TBL] [Abstract][Full Text] [Related]
25. Vascular endothelial growth factors in retinal and choroidal neovascular diseases.
Kinnunen K; Ylä-Herttuala S
Ann Med; 2012 Feb; 44(1):1-17. PubMed ID: 21284527
[TBL] [Abstract][Full Text] [Related]
26. Conbercept (KH-902) for the treatment of neovascular age-related macular degeneration.
Nguyen TT; Guymer R
Expert Rev Clin Pharmacol; 2015; 8(5):541-8. PubMed ID: 26289225
[TBL] [Abstract][Full Text] [Related]
27. Current status of vascular endothelial growth factor inhibition in age-related macular degeneration.
Mousa SA; Mousa SS
BioDrugs; 2010 Jun; 24(3):183-94. PubMed ID: 20210371
[TBL] [Abstract][Full Text] [Related]
28. [Surgical session: neovascular glaucoma and anti-vascular endothelial growth factor treatment].
Laplace O
J Fr Ophtalmol; 2009 Mar; 32(3):230-5. PubMed ID: 19515340
[TBL] [Abstract][Full Text] [Related]
29. Does laser still have a role in the management of retinal vascular and neovascular diseases?
Shah AM; Bressler NM; Jampol LM
Am J Ophthalmol; 2011 Sep; 152(3):332-339.e1. PubMed ID: 21742309
[TBL] [Abstract][Full Text] [Related]
30. Intravitreal and intracameral bevacizumab to treat neovascular complications of retinopathy of prematurity.
dell'Omo R; Kulkarni A; Franks WA
Acta Ophthalmol; 2008 Sep; 86(6):698-700. PubMed ID: 18081905
[No Abstract] [Full Text] [Related]
31. Promising new treatments for neovascular age-related macular degeneration.
Michels S; Schmidt-Erfurth U; Rosenfeld PJ
Expert Opin Investig Drugs; 2006 Jul; 15(7):779-93. PubMed ID: 16787141
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of APE1/Ref-1 for Neovascular Eye Diseases: From Biology to Therapy.
Hartman GD; Lambert-Cheatham NA; Kelley MR; Corson TW
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638620
[TBL] [Abstract][Full Text] [Related]
33. Bevacizumab in glaucoma: a review.
Ichhpujani P; Ramasubramanian A; Kaushik S; Pandav SS
Can J Ophthalmol; 2007 Dec; 42(6):812-5. PubMed ID: 18026201
[TBL] [Abstract][Full Text] [Related]
34. [Treatment of neovascular age-related macular degeneration with antiangiogenic drugs].
Rodrigues EB; Rossi EE; Grumann Junior A; Meyer CH; Ho AC
Arq Bras Oftalmol; 2006; 69(5):756-65. PubMed ID: 17187150
[TBL] [Abstract][Full Text] [Related]
35. Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration.
Ng EW; Adamis AP
Can J Ophthalmol; 2005 Jun; 40(3):352-68. PubMed ID: 15947805
[TBL] [Abstract][Full Text] [Related]
36. The other CNVM: a review of myopic choroidal neovascularization treatment in the age of anti-vascular endothelial growth factor agents.
Adatia FA; Luong M; Munro M; Tufail A
Surv Ophthalmol; 2015; 60(3):204-15. PubMed ID: 25890624
[TBL] [Abstract][Full Text] [Related]
37. Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration.
Kaiser PK; Blodi BA; Shapiro H; Acharya NR;
Ophthalmology; 2007 Oct; 114(10):1868-75. PubMed ID: 17628683
[TBL] [Abstract][Full Text] [Related]
38. Pegaptanib sodium for the treatment of age-related macular degeneration.
Apte RS
Expert Opin Pharmacother; 2008 Feb; 9(3):499-508. PubMed ID: 18220500
[TBL] [Abstract][Full Text] [Related]
39. Combination therapy for the treatment of ocular neovascularization.
Bradley J; Ju M; Robinson GS
Angiogenesis; 2007; 10(2):141-8. PubMed ID: 17372853
[TBL] [Abstract][Full Text] [Related]
40. Targeting VEGF in eye neovascularization: What's new?: A comprehensive review on current therapies and oligonucleotide-based interventions under development.
Amadio M; Govoni S; Pascale A
Pharmacol Res; 2016 Jan; 103():253-69. PubMed ID: 26678602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
